Literature DB >> 4005852

Prominent role of DT-diaphorase as a cellular mechanism reducing chromium(VI) and reverting its mutagenicity.

S De Flora, A Morelli, C Basso, M Romano, D Serra, A De Flora.   

Abstract

Rat liver postmitochondrial (S-12) fractions accounted for the bulk of the activity of whole cell homogenates in reducing chromium(VI) and accordingly in decreasing its mutagenicity. Both cytosolic (S-105) and microsomal fractions concurred to this process, which in all subcellular preparations tested was selectively induced by phenobarbital and especially by Aroclor 1254, but not by 3-methylcholanthrene. Cytosolic fractions were markedly more efficient in reducing chromium(VI) than microsomal fractions recovered from the same amount of tissue (liver or lung), although the latter preparations had a higher specific activity. The microsomal activity was exclusively NADPH dependent. A minor part of the cytosolic reduction was determined by nonenzymatic components, notably by some electron donors and chiefly by reduced glutathione, which proved to reduce chromium(VI) at physiological concentrations. However, also in cytosolic fractions, the most important contribution to chromium reduction was enzyme catalyzed, as shown by the following properties: thermolability; requirement for exogenous NADH or NADPH [supplied as such or in the form of a NADPH-generating system (S-9 mix)]; and saturation by chromium(VI). The likely involvement of DT-diaphorase in this metabolic process is supported by several findings, including its sharp pH dependence and its partial suppression by known inhibitors of this enzyme protein, such as p-chloromercuribenzoate, L-thyroxine, and dicumarol (which conversely did not counteract the metabolic deactivation of the other direct-acting mutagens 2-methoxy-6-chloro-9-[3-(2-chloroethyl)aminopropylamino]acridine 2HCl and epichlorohydrin). Similarly, cytosolic reduction of chromium(VI) was partially inhibited by selective metabolic depletors of both coenzymes of DT-diaphorase, i.e., NADPH and NADH. Pretreatment of rats with enzyme inducers (phenobarbital and 3-methylcholanthrene) stimulated the activity of DT-diaphorase in liver cytosolic fractions. A dramatic stimulation (35 to 40 times over untreated controls) was produced by Aroclor 1254, which also coinduced the liver cytosolic activity of enzymes involved in the glucose 6-phosphate-dependent pathway of both nicotinamide-adenine-dinucleotide phosphate and glutathione reduction (glucose-6-phosphate dehydrogenase, 6-phosphogluconate dehydrogenase, and glutathione reductase). In the lung cytosol, a slight yet significant stimulation of some of these enzyme activities was determined by the daily intratracheal instillations of high doses of chromium(VI) itself for 4 weeks, a condition which has been found to enhance the pulmonary metabolism of this metal ion.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4005852

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

1.  Reduction of chromium(VI) in Chinese hamster V-79 cells.

Authors:  M Sugiyama; K Tsuzuki; T Hidaka; R Ogura; M Yamamoto
Journal:  Biol Trace Elem Res       Date:  1991-07       Impact factor: 3.738

2.  Metabolic reduction of chromium by alveolar macrophages and its relationships to cigarette smoke.

Authors:  F L Petrilli; G A Rossi; A Camoirano; M Romano; D Serra; C Bennicelli; A De Flora; S De Flora
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

3.  Analysis of EDTA-chelatable proteins from DNA-protein crosslinks induced by a carcinogenic chromium(VI) in cultured intact human cells.

Authors:  S N Mattagajasingh; H P Misra
Journal:  Mol Cell Biochem       Date:  1999-09       Impact factor: 3.396

4.  Chromium(VI) stimulates Fyn to initiate innate immune gene induction in human airway epithelial cells.

Authors:  Antonia A Nemec; Lindsey M Zubritsky; Aaron Barchowsky
Journal:  Chem Res Toxicol       Date:  2010-02-15       Impact factor: 3.739

5.  Alterations in the prooxidant and antioxidant status of human leukemic T-lymphocyte MOLT4 cells treated with potassium chromate.

Authors:  S N Mattagajasingh; H P Misra
Journal:  Mol Cell Biochem       Date:  1995-01-12       Impact factor: 3.396

Review 6.  Assessment of the mode of action underlying development of rodent small intestinal tumors following oral exposure to hexavalent chromium and relevance to humans.

Authors:  Chad M Thompson; Deborah M Proctor; Mina Suh; Laurie C Haws; Christopher R Kirman; Mark A Harris
Journal:  Crit Rev Toxicol       Date:  2013-03       Impact factor: 5.635

Review 7.  Emerging role of Nrf2 in adipocytes and adipose biology.

Authors:  Kevin S Schneider; Jefferson Y Chan
Journal:  Adv Nutr       Date:  2013-01-01       Impact factor: 8.701

8.  Mechanism of flavin reduction and oxidation in the redox-sensing quinone reductase Lot6p from Saccharomyces cerevisiae.

Authors:  Sonja Sollner; Sigrid Deller; Peter Macheroux; Bruce A Palfey
Journal:  Biochemistry       Date:  2009-09-15       Impact factor: 3.162

9.  Mitomycin C is not metabolized by but is an inhibitor of human kidney NAD(P)H: (quinone-acceptor)oxidoreductase.

Authors:  J J Schlager; G Powis
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

10.  Hydroxyl radical formation and lipid peroxidation enhancement by chromium. In vitro study.

Authors:  C Coudray; P Faure; S Rachidi; A Jeunet; M J Richard; A M Roussel; A Favier
Journal:  Biol Trace Elem Res       Date:  1992 Jan-Mar       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.